Chronic cancer-related fatigue in long-term survivors of testicular cancer

J Psychosom Res. 2008 Apr;64(4):363-71. doi: 10.1016/j.jpsychores.2008.01.002.

Abstract

Objective: High prevalence of cancer-related fatigue (CRF) has been reported among many groups of cancer survivors when compared to the general population. However, this topic has rarely been studied in long-term survivors of testicular cancer (TCSs). The present multi-centre study examines the prevalence of chronic CRF in Norwegian TCSs compared to chronic general fatigue (GF) in the Norwegian general population, and associations between a variety of relevant variables and CRF in TCSs.

Methods: Participants were 1431 TCSs, aged 18-75, at an average of 11 years posttreatment (range 4.5-21 years), and a sample of 1080 age-matched men from the general Norwegian population (GenPop). The participants responded to a mailed questionnaire that included the Fatigue Questionnaire for the assessment of chronic CRF and chronic GF.

Results: The prevalence of chronic CRF was 17.1% (95% CI 15.2-19.1%) among TCSs compared to 9.7% of chronic GF in GenPop (95% CI 8.0-11.5%). Regression analyses showed that poor quality of life (QOL), various psychosocial and somatic problems, and neuroticism were highly associated with presence of chronic CRF in TCSs.

Conclusion: Chronic CRF is far more common among TCSs than chronic GF in the general population and is associated with poor QOL and multiple psychological and somatic health problems. As a consequence, fatigue should be in focus during routine follow-ups as well as later in the general medical care of TCSs.

Publication types

  • Research Support, Non-U.S. Gov't

MeSH terms

  • Adult
  • Aged
  • Chronic Disease
  • Combined Modality Therapy / psychology
  • Comorbidity
  • Cross-Sectional Studies
  • Fatigue / epidemiology*
  • Fatigue / psychology
  • Health Surveys
  • Humans
  • Male
  • Mental Fatigue / epidemiology
  • Mental Fatigue / psychology
  • Middle Aged
  • Norway
  • Orchiectomy / psychology
  • Reference Values
  • Risk Factors
  • Seminoma / epidemiology*
  • Seminoma / psychology
  • Seminoma / therapy
  • Surveys and Questionnaires
  • Survivors / psychology
  • Survivors / statistics & numerical data*
  • Testicular Neoplasms / epidemiology*
  • Testicular Neoplasms / psychology
  • Testicular Neoplasms / therapy